Skip to main content
Clinical Trials/NCT05738720
NCT05738720
Recruiting
Not Applicable

The Effect of Close Follow-Up Home Based Pulmonary Rehabilitation on Exacerbation Frequency and Hospital Admission in Severe COPD Cases

Saglik Bilimleri Universitesi1 site in 1 country24 target enrollmentFebruary 1, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
COPD Exacerbation
Sponsor
Saglik Bilimleri Universitesi
Enrollment
24
Locations
1
Primary Endpoint
Number of hospital admissions
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

The study is a randomized controlled trial. The cases will be divided into two groups as the Homespirometer group and the control group. Breathing exercises, aerobic exercise and peripheral muscle strengthening will be performed in both groups. A home-type spirometer will be given to the homespirometer group and it will be requested to send the spirometric measurement every week. The cases will be called to the hospital for control and evaluated at baseline, 3rd, 6th and 12th months. Evaluations include assessments such as exercise capacity measurement, muscle strength measurement, disease attack frequency, symptom scoring.

Detailed Description

Pulmonary Rehabilitation (PR) is a comprehensive intervention designed to improve not only exercise, education and behavioral changes, but also the physical and psychological state of individuals, based on detailed patient evaluation and subsequent patient-specific therapies in individuals with chronic respiratory disease. It is integrated into the lifelong care and management of the chronic respiratory patient. It requires an active collaboration between the patient, family, and the Pulmonary Rehabilitation team. Due to the complex nature of respiratory diseases, many disciplines should be involved in the maintenance of treatment. Pulmonary rehabilitation is a useful treatment component in almost all chronic respiratory patients, especially COPD (Chronic obstructive pulmonary disease). There are studies showing that it reduces the number of attacks and the frequency of hospitalization even in COPD patients with frequent attacks. As pulmonary rehabilitation methods; It is possible to see that there are many types such as supervised exercise programs in the hospital, telephone monitoring or home programs.In-hospital supervised programs are time-consuming and costly applications. This situation causes an increase in the tendency towards applications without direct supervision and increases the need for studies on the effectiveness and benefits of these applications. The use of home-type spirometers are practical devices that provide close monitoring of respiratory functions and enable the detection of disease symptoms in a short time. The use of these devices has increased especially during the pandemic period. In a study conducted with asthma patients, it was reported that early diagnosis and intervention is possible in cases with self-monitoring by mobile spirometry. In another study, in which e-monitoring of cases with duchenne muscular dystrophy (DMD) was performed with a spirometer device during the covid 19 pandemic, the importance of regular spirometric follow-ups of DMD cases as a part of their daily routine and making it a part of health care services was emphasized. In our study, advanced stage COPD cases constitute the case group. The exacerbation and hospital admission rates are extremely high in these patients. There are also transfer problems to the hospital due to existing physical limitations. With the planned study, close follow-up of the patients with the help of home-type spirometry will be carried out over a 1-year period, and a pulmonary rehabilitation exercise program will be applied in this process. The effect of the applied follow-up and exercise program on disease exacerbation and hospital admission rates will be examined.

Registry
clinicaltrials.gov
Start Date
February 1, 2023
End Date
December 20, 2026
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

ESRA PEHLIVAN

Assoc. Prof. Dr.

Saglik Bilimleri Universitesi

Eligibility Criteria

Inclusion Criteria

  • Being between the ages of 18-75
  • Having a diagnosis of COPD stages C and D diagnosed according to the GOLD (Global Initiative for Chronic Obstructive Lung Disease) clinical diagnostic criteria
  • Presence of dyspnea on exertion
  • Stable clinical condition at the time of inclusion without infection or exacerbation in the previous 4 weeks
  • Having the ability to use a smart phone and spirometer after training

Exclusion Criteria

  • Patients with severe comorbid diseases, unstable coronary artery disease, collagen vascular diseases and needing high flow oxygen therapy (˃ 3-4 L \\min).
  • A history of effort-related syncope or any comorbidity (such as severe orthopedic or neurological deficits or unstable heart disease) that precludes exercise training.
  • Participation in a pulmonary rehabilitation program within the past 12 months.

Outcomes

Primary Outcomes

Number of hospital admissions

Time Frame: 12 month after the first evaluation

After the first evaluation, he will be questioned at the 12th month follow-ups. Apart from this, patients will be asked to write in the notes section and contact the researchers in case of exacerbation through the spirometer device.

Number of exacerbations follow-up

Time Frame: 12 month after the first evaluation

After the first evaluation, he will be questioned at the 12th month follow-ups. Apart from this, patients will be asked to write in the notes section and contact the researchers in case of exacerbation through the spirometer device.

Secondary Outcomes

  • 6 minutes walking test(Baseline to one year)
  • Modified medical Council Dyspnea score(Baseline to one year)
  • Psychological status assessment(Baseline to one year)
  • Pulmonary Function Test (PFT) with home spirometry for FVC (Forced Vital Capacity) value(Baseline to one year)
  • Daily Saturation Monitoring(Baseline to one year)
  • Peripheral muscle strength measurement(Baseline to one year)
  • Determination of quality of life(Baseline to one year)
  • Pulmonary Function Test (PFT) with home spirometry for FEV1/FVC (Tiffeneau indeksi) value(Baseline to one year)
  • Physical activity level(Baseline to one year)
  • Symptom scoring(Baseline to one year)
  • Heart Rate Monitoring(Baseline to one year)
  • Pulmonary Function Test (PFT) with home spirometry for FEV1 (Forced Expiratory Volume First Second) value(Baseline to one year)
  • Cognitive status assessment(Baseline to one year)

Study Sites (1)

Loading locations...

Similar Trials